Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 37 | 2023 | 707 | 5.490 |
Why?
|
| Magnetic Resonance Imaging | 35 | 2023 | 464 | 3.330 |
Why?
|
| Cognitive Dysfunction | 18 | 2023 | 449 | 3.110 |
Why?
|
| White Matter | 11 | 2022 | 52 | 3.050 |
Why?
|
| Image Processing, Computer-Assisted | 8 | 2021 | 73 | 2.350 |
Why?
|
| Brain Mapping | 10 | 2018 | 59 | 2.120 |
Why?
|
| Alzheimer Disease | 18 | 2023 | 800 | 2.090 |
Why?
|
| Aging | 18 | 2023 | 680 | 1.930 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 9 | 2020 | 36 | 1.900 |
Why?
|
| Nervous System Diseases | 3 | 2022 | 60 | 1.870 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2013 | 38 | 1.330 |
Why?
|
| Aged, 80 and over | 28 | 2023 | 2152 | 1.230 |
Why?
|
| Humans | 57 | 2023 | 12240 | 1.150 |
Why?
|
| Aged | 32 | 2023 | 4000 | 1.120 |
Why?
|
| Neuroimaging | 7 | 2022 | 66 | 1.090 |
Why?
|
| Neural Pathways | 5 | 2020 | 23 | 1.050 |
Why?
|
| Diffusion Tensor Imaging | 7 | 2020 | 26 | 1.010 |
Why?
|
| Male | 38 | 2023 | 6815 | 1.000 |
Why?
|
| Female | 37 | 2023 | 6974 | 0.980 |
Why?
|
| Image Enhancement | 5 | 2013 | 25 | 0.920 |
Why?
|
| Cognition | 12 | 2023 | 641 | 0.920 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 57 | 0.900 |
Why?
|
| Algorithms | 6 | 2014 | 169 | 0.870 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 81 | 0.750 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2022 | 40 | 0.730 |
Why?
|
| Cohort Studies | 13 | 2023 | 827 | 0.700 |
Why?
|
| Organ Size | 6 | 2019 | 41 | 0.680 |
Why?
|
| Nerve Fibers, Myelinated | 4 | 2011 | 11 | 0.670 |
Why?
|
| Connectome | 1 | 2020 | 6 | 0.650 |
Why?
|
| Neuropsychological Tests | 9 | 2021 | 558 | 0.590 |
Why?
|
| Cognition Disorders | 6 | 2023 | 437 | 0.510 |
Why?
|
| Artifacts | 4 | 2014 | 12 | 0.480 |
Why?
|
| Frontal Lobe | 3 | 2019 | 32 | 0.470 |
Why?
|
| Hippocampus | 6 | 2022 | 97 | 0.470 |
Why?
|
| Adult | 12 | 2023 | 3557 | 0.470 |
Why?
|
| Young Adult | 6 | 2020 | 863 | 0.470 |
Why?
|
| Cognitive Aging | 1 | 2016 | 34 | 0.470 |
Why?
|
| Cerebral Infarction | 4 | 2020 | 63 | 0.430 |
Why?
|
| Anisotropy | 6 | 2020 | 25 | 0.420 |
Why?
|
| Postmortem Changes | 2 | 2016 | 17 | 0.410 |
Why?
|
| Longitudinal Studies | 6 | 2020 | 651 | 0.390 |
Why?
|
| Reproducibility of Results | 6 | 2014 | 324 | 0.380 |
Why?
|
| Autopsy | 6 | 2021 | 174 | 0.380 |
Why?
|
| Genome-Wide Association Study | 6 | 2019 | 108 | 0.360 |
Why?
|
| Independent Living | 3 | 2020 | 137 | 0.330 |
Why?
|
| Models, Anatomic | 1 | 2010 | 19 | 0.320 |
Why?
|
| Limbic System | 1 | 2009 | 1 | 0.300 |
Why?
|
| Formaldehyde | 1 | 2009 | 5 | 0.290 |
Why?
|
| Phobic Disorders | 1 | 2009 | 22 | 0.290 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2020 | 29 | 0.290 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 2 | 0.280 |
Why?
|
| Atlases as Topic | 2 | 2020 | 4 | 0.270 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 252 | 0.240 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2019 | 19 | 0.240 |
Why?
|
| Neurodegenerative Diseases | 2 | 2021 | 60 | 0.240 |
Why?
|
| Memory | 4 | 2020 | 112 | 0.230 |
Why?
|
| Temporal Lobe | 3 | 2020 | 29 | 0.220 |
Why?
|
| Neuropathology | 3 | 2020 | 42 | 0.220 |
Why?
|
| Genetic Loci | 3 | 2019 | 25 | 0.210 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 151 | 0.200 |
Why?
|
| Arteriolosclerosis | 1 | 2023 | 25 | 0.200 |
Why?
|
| Tauopathies | 1 | 2023 | 5 | 0.200 |
Why?
|
| Middle Aged | 8 | 2021 | 4043 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 3 | 2020 | 87 | 0.190 |
Why?
|
| DNA Methylation | 3 | 2019 | 93 | 0.190 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 37 | 0.190 |
Why?
|
| Health Literacy | 1 | 2023 | 45 | 0.190 |
Why?
|
| Inflammation | 2 | 2016 | 124 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2019 | 44 | 0.180 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 110 | 0.180 |
Why?
|
| Proteomics | 1 | 2022 | 39 | 0.170 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 6 | 0.170 |
Why?
|
| Neuropeptides | 2 | 2020 | 17 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 97 | 0.170 |
Why?
|
| Psychomotor Performance | 2 | 2020 | 85 | 0.170 |
Why?
|
| Proteins | 1 | 2020 | 33 | 0.160 |
Why?
|
| Neurologic Examination | 1 | 2020 | 49 | 0.160 |
Why?
|
| Diabetes Complications | 1 | 2020 | 28 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 83 | 0.160 |
Why?
|
| Amyloid Neuropathies | 1 | 2020 | 3 | 0.160 |
Why?
|
| Cost of Illness | 1 | 2020 | 24 | 0.150 |
Why?
|
| Motor Skills | 2 | 2021 | 32 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2019 | 2 | 0.150 |
Why?
|
| Adenylate Kinase | 1 | 2019 | 5 | 0.150 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 5 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 14 | 0.150 |
Why?
|
| Parietal Lobe | 1 | 2019 | 11 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 26 | 0.150 |
Why?
|
| Nerve Fibers | 2 | 2014 | 5 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 45 | 0.150 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 20 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 60 | 0.150 |
Why?
|
| Transcriptome | 1 | 2019 | 32 | 0.150 |
Why?
|
| Motor Disorders | 1 | 2019 | 13 | 0.150 |
Why?
|
| Exercise | 1 | 2021 | 233 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 182 | 0.140 |
Why?
|
| Disease Progression | 1 | 2020 | 290 | 0.140 |
Why?
|
| Kidney | 1 | 2019 | 87 | 0.140 |
Why?
|
| Lateral Ventricles | 1 | 2018 | 2 | 0.140 |
Why?
|
| Genome, Human | 1 | 2018 | 21 | 0.140 |
Why?
|
| Delay Discounting | 1 | 2018 | 7 | 0.140 |
Why?
|
| Datasets as Topic | 1 | 2018 | 1 | 0.140 |
Why?
|
| Adolescent | 2 | 2018 | 989 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 36 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2017 | 157 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 15 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 18 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 69 | 0.120 |
Why?
|
| Intelligence | 1 | 2016 | 10 | 0.120 |
Why?
|
| Comprehension | 1 | 2016 | 11 | 0.120 |
Why?
|
| Economics | 1 | 2016 | 8 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2016 | 11 | 0.120 |
Why?
|
| Gray Matter | 1 | 2016 | 11 | 0.120 |
Why?
|
| Neocortex | 1 | 2016 | 17 | 0.120 |
Why?
|
| Sleep Deprivation | 1 | 2016 | 15 | 0.120 |
Why?
|
| Microglia | 1 | 2016 | 64 | 0.110 |
Why?
|
| Evoked Potentials | 2 | 2007 | 8 | 0.110 |
Why?
|
| Age Factors | 1 | 2016 | 350 | 0.110 |
Why?
|
| Corpus Callosum | 1 | 2014 | 4 | 0.100 |
Why?
|
| Pyramidal Tracts | 1 | 2014 | 2 | 0.100 |
Why?
|
| Dominance, Cerebral | 1 | 2013 | 7 | 0.100 |
Why?
|
| Reference Values | 1 | 2013 | 103 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 175 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 156 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2013 | 117 | 0.090 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 12 | 0.090 |
Why?
|
| Movement Disorders | 1 | 2012 | 32 | 0.090 |
Why?
|
| Cadaver | 1 | 2013 | 166 | 0.090 |
Why?
|
| tau Proteins | 2 | 2023 | 88 | 0.090 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 98 | 0.090 |
Why?
|
| Dementia | 2 | 2012 | 236 | 0.090 |
Why?
|
| Risk-Taking | 1 | 2011 | 18 | 0.090 |
Why?
|
| Biomarkers | 3 | 2019 | 294 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 77 | 0.080 |
Why?
|
| Motion | 1 | 2009 | 11 | 0.070 |
Why?
|
| Fixatives | 1 | 2009 | 4 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 132 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2009 | 256 | 0.070 |
Why?
|
| Genotype | 2 | 2019 | 169 | 0.070 |
Why?
|
| Phenotype | 2 | 2019 | 157 | 0.070 |
Why?
|
| Probability | 2 | 2021 | 45 | 0.060 |
Why?
|
| Nerve Net | 2 | 2019 | 22 | 0.060 |
Why?
|
| Software | 1 | 2005 | 26 | 0.060 |
Why?
|
| Alleles | 2 | 2017 | 119 | 0.060 |
Why?
|
| Actigraphy | 2 | 2016 | 41 | 0.060 |
Why?
|
| Depression | 2 | 2017 | 229 | 0.050 |
Why?
|
| Risk Factors | 2 | 2019 | 1049 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 36 | 0.050 |
Why?
|
| Oligodendroglioma | 1 | 2002 | 2 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2002 | 6 | 0.050 |
Why?
|
| Biological Clocks | 1 | 2002 | 5 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 35 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 47 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 695 | 0.040 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2020 | 4 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2023 | 817 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 6 | 0.040 |
Why?
|
| Actinin | 1 | 2020 | 7 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 10 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2020 | 8 | 0.040 |
Why?
|
| Epoxide Hydrolases | 1 | 2020 | 7 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 28 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 79 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 28 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2020 | 24 | 0.040 |
Why?
|
| Heredity | 1 | 2019 | 2 | 0.040 |
Why?
|
| United Kingdom | 1 | 2019 | 23 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 27 | 0.040 |
Why?
|
| Demography | 1 | 2018 | 37 | 0.030 |
Why?
|
| Linear Models | 1 | 2018 | 115 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 12 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 17 | 0.030 |
Why?
|
| Sclerosis | 1 | 2017 | 32 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 23 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 166 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 17 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 18 | 0.030 |
Why?
|
| Lewy Bodies | 1 | 2017 | 96 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 7 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 726 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 43 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 30 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 8 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 23 | 0.030 |
Why?
|
| Arterial Pressure | 1 | 2016 | 5 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 55 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 546 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 66 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 20 | 0.030 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 97 | 0.030 |
Why?
|
| Child | 1 | 2017 | 614 | 0.030 |
Why?
|
| Logistic Models | 1 | 2015 | 196 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 100 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 117 | 0.030 |
Why?
|
| Sleep | 1 | 2016 | 155 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2016 | 314 | 0.020 |
Why?
|
| Games, Experimental | 1 | 2011 | 5 | 0.020 |
Why?
|
| Atrophy | 1 | 2011 | 29 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 26 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 151 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 400 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2007 | 11 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2002 | 8 | 0.010 |
Why?
|
| Glioblastoma | 1 | 2002 | 8 | 0.010 |
Why?
|
| Fingers | 1 | 2002 | 5 | 0.010 |
Why?
|
| Evoked Potentials, Motor | 1 | 2002 | 3 | 0.010 |
Why?
|
| Echo-Planar Imaging | 1 | 2002 | 3 | 0.010 |
Why?
|
| Motor Cortex | 1 | 2002 | 9 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2002 | 21 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 51 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 23 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2002 | 40 | 0.010 |
Why?
|
| Reaction Time | 1 | 2002 | 53 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 61 | 0.010 |
Why?
|
| Movement | 1 | 2002 | 58 | 0.010 |
Why?
|